Literature DB >> 25588111

Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.

Johan Vad-Nielsen1, Anders Lade Nielsen.   

Abstract

Heterochromatin protein 1α (HP1α) encoded from the CBX5-gene is an evolutionary conserved protein that binds histone H3 di- or tri-methylated at position lysine 9 (H3K9me2/3), a hallmark for heterochromatin, and has an essential role in forming higher order chromatin structures. HP1α has diverse functions in heterochromatin formation, gene regulation, and mitotic progression, and forms complex networks of gene, RNA, and protein interactions. Emerging evidence has shown that HP1α serves a unique biological role in breast cancer related processes and in particular for epigenetic control mechanisms involved in aberrant cell proliferation and metastasis. However, how HP1α deregulation plays dual mechanistic functions for cancer cell proliferation and metastasis suppression and the underlying cellular mechanisms are not yet comprehensively described. In this paper we provide an overview of the role of HP1α as a new sight of epigenetics in proliferation and metastasis of human breast cancer. This highlights the importance of addressing HP1α in breast cancer diagnostics and therapeutics.

Entities:  

Keywords:  CBX, chromobox homolog; CD, chromo domain; CSC, cancer stem cells; CSD, cromo shadow domain; CTE, C-terminal extension; DNMT, DNA-methyltransferase; EMT, epithelial-to-mesenchymal transition; HDMT, histone demethylase; HMT, histone methyltransferase; HP1, heterochromatin protein 1; NTE, N-terminal extension; PEV, position effect variegation; SOMU, sumoylation; TGS, transcriptional gene silencing; TSS, transcriptional start site; bp, base pair; breast-cancer, metastasis; chromatin; epigenetics; histone-modifications; invasion; mitosis; proliferation

Mesh:

Substances:

Year:  2015        PMID: 25588111      PMCID: PMC4622548          DOI: 10.1080/15384047.2014.1001277

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  149 in total

1.  Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing.

Authors:  Robert J Sims; Scott Millhouse; Chi-Fu Chen; Brian A Lewis; Hediye Erdjument-Bromage; Paul Tempst; James L Manley; Danny Reinberg
Journal:  Mol Cell       Date:  2007-11-30       Impact factor: 17.970

2.  Transcription factor binding and modified histones in human bidirectional promoters.

Authors:  Jane M Lin; Patrick J Collins; Nathan D Trinklein; Yutao Fu; Hualin Xi; Richard M Myers; Zhiping Weng
Journal:  Genome Res       Date:  2007-06       Impact factor: 9.043

3.  Analysis of the human HP1 interactome reveals novel binding partners.

Authors:  Claire Rosnoblet; Julien Vandamme; Pamela Völkel; Pierre-Olivier Angrand
Journal:  Biochem Biophys Res Commun       Date:  2011-08-24       Impact factor: 3.575

Review 4.  The histone tails of the nucleosome.

Authors:  K Luger; T J Richmond
Journal:  Curr Opin Genet Dev       Date:  1998-04       Impact factor: 5.578

Review 5.  Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).

Authors:  Giuseppe Biamonti; Serena Bonomi; Stefania Gallo; Claudia Ghigna
Journal:  Cell Mol Life Sci       Date:  2012-02-19       Impact factor: 9.261

6.  Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR.

Authors:  Q Ye; I Callebaut; A Pezhman; J C Courvalin; H J Worman
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

7.  Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes.

Authors:  Jonathan Baxter; Stephan Sauer; Antoine Peters; Rosalind John; Ruth Williams; Marie-Laure Caparros; Katharine Arney; Arie Otte; Thomas Jenuwein; Matthias Merkenschlager; Amanda G Fisher
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

Review 8.  The many faces of histone lysine methylation.

Authors:  Monika Lachner; Thomas Jenuwein
Journal:  Curr Opin Cell Biol       Date:  2002-06       Impact factor: 8.382

9.  RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol II.

Authors:  Mikel Zaratiegui; Stephane E Castel; Danielle V Irvine; Anna Kloc; Jie Ren; Fei Li; Elisa de Castro; Laura Marín; An-Yun Chang; Derek Goto; W Zacheus Cande; Francisco Antequera; Benoit Arcangioli; Robert A Martienssen
Journal:  Nature       Date:  2011-10-16       Impact factor: 49.962

10.  Dynamic phosphorylation of HP1α regulates mitotic progression in human cells.

Authors:  Arindam Chakraborty; Kannanganattu V Prasanth; Supriya G Prasanth
Journal:  Nat Commun       Date:  2014-03-12       Impact factor: 14.919

View more
  16 in total

1.  Heterochromatin Protein 1 (HP1) inhibits stem cell proliferation induced by ectopic activation of the Jak/STAT pathway in the Drosophila testis.

Authors:  Mariano A Loza-Coll; Cynthia C Petrossian; Monica L Boyle; D Leanne Jones
Journal:  Exp Cell Res       Date:  2019-02-25       Impact factor: 3.905

2.  The mouse HP1 proteins are essential for preventing liver tumorigenesis.

Authors:  Nehmé Saksouk; Shefqet Hajdari; Yannick Perez; Marine Pratlong; Célia Barrachina; Céline Graber; Damien Grégoire; Aliki Zavoriti; Amélie Sarrazin; Nelly Pirot; Jean-Yohan Noël; Lakhdar Khellaf; Eric Fabbrizio; Eric Julien; Florence M Cammas
Journal:  Oncogene       Date:  2020-02-04       Impact factor: 9.867

3.  Systematic Variation of Both the Aromatic Cage and Dialkyllysine via GCE-SAR Reveal Mechanistic Insights in CBX5 Reader Protein Binding.

Authors:  Kelsey M Kean; Stefanie A Baril; Kelsey N Lamb; Sarah N Dishman; Joseph W Treacy; Kendall N Houk; Eric M Brustad; Lindsey I James; Marcey L Waters
Journal:  J Med Chem       Date:  2022-01-11       Impact factor: 7.446

Review 4.  Biomolecular Condensates and Cancer.

Authors:  Ann Boija; Isaac A Klein; Richard A Young
Journal:  Cancer Cell       Date:  2021-01-07       Impact factor: 31.743

5.  Methyl-CpG-binding (SmMBD2/3) and chromobox (SmCBX) proteins are required for neoblast proliferation and oviposition in the parasitic blood fluke Schistosoma mansoni.

Authors:  Kathrin K Geyer; Sabrina E Munshi; Helen L Whiteland; Narcis Fernandez-Fuentes; Dylan W Phillips; Karl F Hoffmann
Journal:  PLoS Pathog       Date:  2018-06-28       Impact factor: 6.823

6.  HP1α is a chromatin crosslinker that controls nuclear and mitotic chromosome mechanics.

Authors:  Amy R Strom; Ronald J Biggs; Edward J Banigan; Xiaotao Wang; Katherine Chiu; Cameron Herman; Jimena Collado; Feng Yue; Joan C Ritland Politz; Leah J Tait; David Scalzo; Agnes Telling; Mark Groudine; Clifford P Brangwynne; John F Marko; Andrew D Stephens
Journal:  Elife       Date:  2021-06-09       Impact factor: 8.713

7.  Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1α down-regulation in metastatic cells.

Authors:  Johan Vad-Nielsen; Kristine Raaby Jakobsen; Tina Fuglsang Daugaard; Rune Thomsen; Anja Brügmann; Boe Sandahl Sørensen; Anders Lade Nielsen
Journal:  BMC Cancer       Date:  2016-01-20       Impact factor: 4.430

8.  Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.

Authors:  Jiahui An; Mengying Wu; Xiaoru Xin; Zhuojia Lin; Xiaonan Li; Qidi Zheng; Xin Gui; Tianming Li; Hu Pu; Haiyan Li; Dongdong Lu
Journal:  Oncotarget       Date:  2016-08-02

9.  Inflammatory factor receptor Toll-like receptor 4 controls telomeres through heterochromatin protein 1 isoforms in liver cancer stem cell.

Authors:  Qidi Zheng; Jie Xu; Zhuojia Lin; Yanan Lu; Xiaoru Xin; Xiaonan Li; Yuxin Yang; Qiuyu Meng; Chen Wang; Wujun Xiong; Dongdong Lu
Journal:  J Cell Mol Med       Date:  2018-03-30       Impact factor: 5.310

10.  Prognosis and Immune Infiltration of Chromobox Family Genes in Sarcoma.

Authors:  Jian Zhou; Ziyuan Chen; Ming Zou; Rongjun Wan; Tong Wu; Yingquan Luo; Gen Wu; Wanchun Wang; Tang Liu
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.